Gaël Grandmaison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gaël Grandmaison has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Julien Vaucher
Division of Internal Medicine, University and Hospital of Fribourg, Fribourg, Switzerland
4 shared publications- Marco Mancinetti
Affiliations Department of Medicine, Hôpital Cantonal de Fribourg, Fribourg, Switzerland, Medical Education Unit, University of Fribourg, Fribourg, Switzerland
2 shared publications Philipp Suter
Division of Pulmonology, Department of Medicine and Specialties, Fribourg Hospital and University of Fribourg, Fribourg, Switzerland
2 shared publications- Philipp Suter
Scottish Centre for Respiratory Research and ENT clinic, Ninewells Hospital and Medical School, University of Dundee, UK
2 shared publications Thomas Grobéty
Division of Physiotherapy, Hospital of Fribourg, Fribourg, Switzerland
2 shared publications- Anne-Catherine Barras-Moret
HFR, Department of Internal Medicine, University and Hospital of Fribourg, Switzerland
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e004540
Reducing inhaler misuse in COPD outpatients: protocol for a randomised trial
- 13 November 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e004540
Open AccessReducing inhaler misuse in COPD outpatients: protocol for a randomised trial
- Open Access
- 23 June 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (6) , e270897
Isaacs syndrome associated with polyarteritis nodosa
Isaacs syndrome (IS) is a rare peripheral nerve hyperexcitability disorder, often associated with an underlying disease. We report a clinical case which appears to be a previously unreported co-occurrence of IS and systemic polyarteritis nodosa, diagnosed in a young woman presenting with subacute back pain, weight loss, fasciculations, diaphoresis, tachycardia, micturition disorder, constipation, cutaneous lesions and mesenteric vasculitis on MRI. The patient achieved clinical remission following treatment with intravenous cyclophosphamide and corticosteroids.
- 23 June 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (6) , e270897
Open AccessIsaacs syndrome associated with polyarteritis nodosa
Isaacs syndrome (IS) is a rare peripheral nerve hyperexcitability disorder, often associated with an underlying disease. We report a clinical case which appears to be a previously unreported co-occurrence of IS and systemic polyarteritis nodosa, diagnosed in a young woman presenting with subacute back pain, weight loss, fasciculations, diaphoresis, tachycardia, micturition disorder, constipation, cutaneous lesions and mesenteric vasculitis on MRI. The patient achieved clinical remission following treatment with intravenous cyclophosphamide and corticosteroids.
- Open Access
- 1 April 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 957-969
Evolution of Peak Inspiratory Flow During Hospitalization of Patients with COPD – A Prospective Monocentric Observational Study
Purpose: Effective treatment of chronic obstructive pulmonary disease (COPD) primarily relies on treatment delivered through inhaler devices. The effectiveness of dry powder inhalers is compromised by insufficient peak inspiratory flow (PIF). Understanding the evolution of PIF during hospitalization is crucial for optimizing inhaler selection and improving patient outcomes. Patients and Methods: A prospective monocentric observational study was conducted at Fribourg Hospital, Switzerland, from August 2022 to December 2022. PIF was assessed at hospital admission and discharge in all patients with COPD admitted to the internal medicine division. The primary outcome was the evolution of maximum PIF at a fixed medium-low resistance (R2) during hospitalization. Secondary outcomes included the variation of PIF in the intra-assessment evaluation and transitioning between sufficient and insufficient PIF. Results: Forty-nine patients were enrolled, 61% were men and 65% experienced an acute COPD exacerbation (AECOPD). The maximum PIF for R2 increased from 64.8 ± 17.2 L/min at admission to 70.7 ± 17.9 L/min at discharge, showing a 5.9 L/min improvement (95% CI: 2.4– 9.5, p < 0.01). A hospitalization > 5 days in patients hospitalized for an AECOPD is associated with a higher increase in PIF (p < 0.05). In the intra-assessment measurement, we observed an increase in PIF in the successive measurements (p < 0.01). Conclusion: Hospitalized patients with COPD experienced a significant increase in PIF during their stay. These results appear to be independent of the reason for hospitalization but need to be confirmed with a larger sample. Nevertheless, these findings underscore the importance of regular PIF assessment and influence inhaler selection.
- 1 April 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 957-969
Open AccessEvolution of Peak Inspiratory Flow During Hospitalization of Patients with COPD – A Prospective Monocentric Observational Study
Purpose: Effective treatment of chronic obstructive pulmonary disease (COPD) primarily relies on treatment delivered through inhaler devices. The effectiveness of dry powder inhalers is compromised by insufficient peak inspiratory flow (PIF). Understanding the evolution of PIF during hospitalization is crucial for optimizing inhaler selection and improving patient outcomes. Patients and Methods: A prospective monocentric observational study was conducted at Fribourg Hospital, Switzerland, from August 2022 to December 2022. PIF was assessed at hospital admission and discharge in all patients with COPD admitted to the internal medicine division. The primary outcome was the evolution of maximum PIF at a fixed medium-low resistance (R2) during hospitalization. Secondary outcomes included the variation of PIF in the intra-assessment evaluation and transitioning between sufficient and insufficient PIF. Results: Forty-nine patients were enrolled, 61% were men and 65% experienced an acute COPD exacerbation (AECOPD). The maximum PIF for R2 increased from 64.8 ± 17.2 L/min at admission to 70.7 ± 17.9 L/min at discharge, showing a 5.9 L/min improvement (95% CI: 2.4– 9.5, p < 0.01). A hospitalization > 5 days in patients hospitalized for an AECOPD is associated with a higher increase in PIF (p < 0.05). In the intra-assessment measurement, we observed an increase in PIF in the successive measurements (p < 0.01). Conclusion: Hospitalized patients with COPD experienced a significant increase in PIF during their stay. These results appear to be independent of the reason for hospitalization but need to be confirmed with a larger sample. Nevertheless, these findings underscore the importance of regular PIF assessment and influence inhaler selection.
- 10 January 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (1) , e258427
Left hepatic hydrothorax without ascites
Hepatic hydrothorax (HH) is a complication in patients with cirrhosis and portal hypertension. It predominantly presents in the right pleural cavity and usually associates with ascites. Few cases of HH occurring without detectable ascites have been reported. This case report comprehensively presents a case of a refractory left unilateral HH without ascites. The patient benefited from palliative care and the HH was managed using a semipermanent indwelling pleural catheter until she died 3 months after diagnosis.
- 10 January 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (1) , e258427
Left hepatic hydrothorax without ascites
Hepatic hydrothorax (HH) is a complication in patients with cirrhosis and portal hypertension. It predominantly presents in the right pleural cavity and usually associates with ascites. Few cases of HH occurring without detectable ascites have been reported. This case report comprehensively presents a case of a refractory left unilateral HH without ascites. The patient benefited from palliative care and the HH was managed using a semipermanent indwelling pleural catheter until she died 3 months after diagnosis.
- 1 January 2024
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 11 (4) , 406-415
Prevalence of Critical Errors and Insufficient Peak Inspiratory Flow in Patients Hospitalized With COPD in a Department of General Internal Medicine: A Cross-Sectional Study
Background: The suboptimal use of inhalers in the treatment of patients with chronic obstructive pulmonary disease (COPD) is probably a major but poorly documented problem in hospitalized patients. We aimed to describe the prevalence of misused inhalers among patients hospitalized with COPD in a department of general internal medicine. Methods: We conducted a monocentric cross-sectional- sectional study in consecutive patients with a diagnosis of COPD and hospitalized between August 2022 and April 2023 in the internal medicine division of Fribourg Hospital, Switzerland. Patients underwent an assessment of their inhaler technique and peak inspiratory flow (PIF) using the In- Check Dial G16 (R). (R) . The primary outcome was the prevalence of misused inhalers, defined as an inhaler used with a critical error and/or insufficient PIF. Secondary outcomes included the prevalence of inhalers unsuitable to patients' characteristics and of patients using at least one misused inhaler. Results: The study included 96 patients and 160 inhalers were assessed at admission. Among these inhalers, 111 (69.4%; 95% confidence interval [CI] 61.6-76.4) were misused; 105 (65.6%; 95% CI 57.7-72.9) due to the presence of a critical error in the inhalation technique and 22 (13.8%; 95% CI 8.8-20.1) due to insufficient PIF. Concerning the secondary outcome, 27 inhalers (16.9%) were unsuitable, and 79 patients (82.3%) used at least one misused inhaler. Conclusion: Among patients hospitalized with a diagnosis of COPD, two-thirds- thirds of inhalers were misused. Suboptimal use was mainly due to the presence of critical errors, but also to the presence of an insufficient PIF and unsuitable inhalers.
- 1 January 2024
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 11 (4) , 406-415
Prevalence of Critical Errors and Insufficient Peak Inspiratory Flow in Patients Hospitalized With COPD in a Department of General Internal Medicine: A Cross-Sectional Study
Background: The suboptimal use of inhalers in the treatment of patients with chronic obstructive pulmonary disease (COPD) is probably a major but poorly documented problem in hospitalized patients. We aimed to describe the prevalence of misused inhalers among patients hospitalized with COPD in a department of general internal medicine. Methods: We conducted a monocentric cross-sectional- sectional study in consecutive patients with a diagnosis of COPD and hospitalized between August 2022 and April 2023 in the internal medicine division of Fribourg Hospital, Switzerland. Patients underwent an assessment of their inhaler technique and peak inspiratory flow (PIF) using the In- Check Dial G16 (R). (R) . The primary outcome was the prevalence of misused inhalers, defined as an inhaler used with a critical error and/or insufficient PIF. Secondary outcomes included the prevalence of inhalers unsuitable to patients' characteristics and of patients using at least one misused inhaler. Results: The study included 96 patients and 160 inhalers were assessed at admission. Among these inhalers, 111 (69.4%; 95% confidence interval [CI] 61.6-76.4) were misused; 105 (65.6%; 95% CI 57.7-72.9) due to the presence of a critical error in the inhalation technique and 22 (13.8%; 95% CI 8.8-20.1) due to insufficient PIF. Concerning the secondary outcome, 27 inhalers (16.9%) were unsuitable, and 79 patients (82.3%) used at least one misused inhaler. Conclusion: Among patients hospitalized with a diagnosis of COPD, two-thirds- thirds of inhalers were misused. Suboptimal use was mainly due to the presence of critical errors, but also to the presence of an insufficient PIF and unsuitable inhalers.
- 13 August 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 57, 624-629
Survey of dietary beliefs and habits of inflammatory bowel disease patients
- 13 August 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 57, 624-629
Survey of dietary beliefs and habits of inflammatory bowel disease patients
- 10 May 2023
- Published by S. Karger AG in Respiration
- Vol. 102 (6) , 416-425
Patient Characteristics to Consider When Selecting an Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease and Available Assessment Methods: A Narrative Review
Inhaler misuse is common among patients with chronic obstructive pulmonary disease and associated with poor disease control. Many patient characteristics are reported to impact inhaler use, but there are no studies in the literature on the best way to evaluate them. This narrative review aims to identify patient characteristics that influence the correct use of an inhaler and describe the tools available for their assessment. First, we searched four different databases to identify reviews describing patient characteristics reported to impact inhaler use. In a second step, ways to characterize these aspects were searched using the same databases. Fifteen patient characteristics impacting on the use of inhalers were identified. Peak inspiratory flow, dexterity, and cognitive impairment were the most studied characteristics and appeared to have the highest impact on the correct use of inhalers. Notably, peak inspiratory flow can be reliably assessed in clinical practice using the In-Check Dial®. Triggering coordination, breath retention, collaboration/consciousness, and muscle strength in the fingers were important characteristics, but insufficient data exist to recommend the use of a specific tool for their assessment in daily practice. Other identified characteristics have a more uncertain impact. A demonstration of inhalation technique by the patient, combined with the measurement of peak inspiratory flow using the In-Check Dial®, appears to be an effective strategy to assess the characteristics with the highest impact on the correct use of an inhaler. In the future, “smart” inhalers could also play a decisive role in this area.
- 10 May 2023
- Published by S. Karger AG in Respiration
- Vol. 102 (6) , 416-425
Patient Characteristics to Consider When Selecting an Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease and Available Assessment Methods: A Narrative Review
Inhaler misuse is common among patients with chronic obstructive pulmonary disease and associated with poor disease control. Many patient characteristics are reported to impact inhaler use, but there are no studies in the literature on the best way to evaluate them. This narrative review aims to identify patient characteristics that influence the correct use of an inhaler and describe the tools available for their assessment. First, we searched four different databases to identify reviews describing patient characteristics reported to impact inhaler use. In a second step, ways to characterize these aspects were searched using the same databases. Fifteen patient characteristics impacting on the use of inhalers were identified. Peak inspiratory flow, dexterity, and cognitive impairment were the most studied characteristics and appeared to have the highest impact on the correct use of inhalers. Notably, peak inspiratory flow can be reliably assessed in clinical practice using the In-Check Dial®. Triggering coordination, breath retention, collaboration/consciousness, and muscle strength in the fingers were important characteristics, but insufficient data exist to recommend the use of a specific tool for their assessment in daily practice. Other identified characteristics have a more uncertain impact. A demonstration of inhalation technique by the patient, combined with the measurement of peak inspiratory flow using the In-Check Dial®, appears to be an effective strategy to assess the characteristics with the highest impact on the correct use of an inhaler. In the future, “smart” inhalers could also play a decisive role in this area.
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 264-266
Pédagogie de l’incertitude en médecine
L’objectif de cet article est d’apporter des pistes pédagogiques permettant d’enseigner la gestion de l’incertitude en médecine. En premier lieu, il s’a...
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 264-266
Pédagogie de l’incertitude en médecine
L’objectif de cet article est d’apporter des pistes pédagogiques permettant d’enseigner la gestion de l’incertitude en médecine. En premier lieu, il s’a...
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 258-262
Communiquer l’incertitude : un mal nécessaire ?
L’incertitude est omniprésente dans la pratique médicale. Elle apparaît quand les données à disposition ne permettent pas de prédire avec exactitude le...
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 258-262
Communiquer l’incertitude : un mal nécessaire ?
L’incertitude est omniprésente dans la pratique médicale. Elle apparaît quand les données à disposition ne permettent pas de prédire avec exactitude le...
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 255-256
L’incertitude en médecine
La Revue Médicale Suisse est la revue de formation continue de référence pour les médecins praticiens.
- 1 January 2023
- Published by Médecine et Hygiène in Revue Medicale Suisse
- Vol. 19 (813) , 255-256
L’incertitude en médecine
La Revue Médicale Suisse est la revue de formation continue de référence pour les médecins praticiens.